603229.SS
603229.SS
CNE100002XK2
ZHEJIANG AUSUN PHARMACEUTICAL C
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 792.759.012 795.288.309
0.3%
Cost of Revenue 368.562.171 363.980.824
1.3%
Gross Profit 424.196.841 431.307.485
1.6%
285.570.949 225.438.666
26.7%
Operating Income 138.625.892 205.868.819
32.7%
Pretax Income 137.903.857 240.200.049
42.6%
Net Income Common Stockholders 130.570.124 206.791.017
36.9%
-- --
--
-- --
--
ende